Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl 2-((tert-butoxycarbonyl)(methyl)amino)ethyl(3-(5-((2,3-dihydrobenzo[b][1,4]dioxin-5-yl-methyl)carbamoyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzyl)carbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1051929-86-2

Post Buying Request

1051929-86-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1051929-86-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1051929-86-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,1,9,2 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1051929-86:
(9*1)+(8*0)+(7*5)+(6*1)+(5*9)+(4*2)+(3*9)+(2*8)+(1*6)=152
152 % 10 = 2
So 1051929-86-2 is a valid CAS Registry Number.

1051929-86-2Downstream Products

1051929-86-2Relevant academic research and scientific papers

1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)

Therrien, Eric,Larouche, Guillaume,Manku, Sukhdev,Allan, Martin,Nguyen, Natalie,Styhler, Sylvia,Robert, Marie-France,Goulet, Anne-Christine,Besterman, Jeffrey M.,Nguyen, Hannah,Wahhab, Amal

scheme or table, p. 6725 - 6732 (2010/06/12)

We have identified the N1-benzyl-N2-methylethane-1,2-diamine unit as a substitute for the (S)-alanine benzylamide moiety for the design of co-activator associated arginine methyltransferase 1 (CARM1) inhibitors. The potency of these

SMALL MOLECULE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASES (PRMTS)

-

Page/Page column 94-95, (2008/12/08)

The present invention relates to compounds that are useful as inhibitors of protein arginine methyltransferase that have a formula selected from Formula (I), Formula (II) and Formula (III), as well as racemic mixtures, diastereomers, enantiomers and tautomers thereof and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof as defined herein. Said compound are useful as inhibitors of PRMTs and/or CARM-I. The invention further relates to compositions comprising such compounds and methods for their use.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1051929-86-2